Biopharmaceutical Analysis

Considerable efforts have been made over the years to resolve the key issues of stability and delivery of RNA-based therapeutics.

Bio-Rad’s newly launched StarBright Blue and StarBright Yellow dyes are intended for use in various flow cytometry applications.

Eurofins Viracor ExPeCT CAR-T qPCR assay is a tool designed for monitoring and optimizating CAR-T therapies.

Webinar Date/Time: Wed, Mar 8, 2023 11:00 AM EST

Webinar Date/Time: Thu, Mar 9, 2023 11:00 AM EST

Webinar Date/Time: Tue, Mar 14, 2023 11:00 AM EDT

Variability instills consistency in advanced therapy medicinal products.

Scientific Laboratory Supplies’ acquisition of C&M will bolster the company’s scientific calibration, maintenance, and validation offerings.

Agilent will work with Quest Diagnostics to distribute the ctDx FIRST test.

The BioProfile FAST CDV is a fully automated viable cell density and viability analyzer.

Pfizer and Gero have partnered to discover potential therapeutic targets for fibrotic diseases using machine learning technology.

The collaboration between AbbVie and Anima Biotech will combine Anima's mRNA Lightning technology platform with AbbVie's extensive expertise in oncology and immunology.

Advanced LC technologies can streamline the review process for LC equipment maintenance.

Biologic drug development requires relevant bioassays to measure and help predict cellular response.

Webinar Date/Time: Monday, March 20th, 2023 at 11am EDT|8am PDT|3pm GMT|4pm CET

The launch of Discovery Life Sciences’ new Proteomic Services Division offers a single source for large-scale population studies, biobank characterization, and multi-omic biomarker analysis.

Generate Biomedicines published a preprint describing technology that can generate novel proteins towards desired functional or other properties.

PictorLabs, a digital pathology company developing an AI-powered virtual staining platform, formally announced its launch at the start of December.

The design of viral clearance studies must keep pace with the quickly evolving biologic drugs industry.

Biotech startup, Cradle, has raised $5.4 million in seed funding with an AI-enabled design platform that allows for the synthetic building of cell factories to produce proteins.

Webinar Date/Time: Tue, Dec 6, 2022 11:00 AM EST

Webinar Date/Time: Wed, Dec 14, 2022 11:00 AM EST

Webinar Date/Time: Friday, December 9th, 2022 at 11am EST|8am PST|4pm GMT|5pm CET

A novel mathematical approach for fitting concentration-response curves is proposed that offers a more accurate estimation of potency data.

Webinar Date/Time: Thu, Dec 1, 2022 11:00 AM EST